Table 1.
Chemotherapy regimens, dosages, post-cooling times and number of patients who finished the DigniCap evaluation
| Chemotherapy regimen and doses | No of patients | Post-cooling time (min) |
|---|---|---|
| (Neo-)adjuvant CT | ||
| E90C600 (q3w*4) - > Doc100/175 (q3w*4)1 | 32 | 100 |
| F500E100C500 (q3w*6) | 15 | 120 |
| F500E100C500 (q3w*3) - > Doc100 (q3w*3) | 7 | 120 - > 100 |
| E90C600 (q3w*4) | 3 | 100 |
| CarboPt/Doc (q3w*6) | 1 | 90 |
| Palliative CT | ||
| Taxol135/Herceptin8mg/kg | 1 | 90 |
| Halaven1.23 | 1 | 120 |
| Taxol90/Avastin10mg/kg | 3 | 60 |
| Carboplatin | 1 | 90 |
| Gemcitabine/Cisplatin | (12) | 60 |
1Three patients were included receiving three-weekly (neo-)adjuvant Doc/EC. Of them, one patient was treated with Doc175 and two with Doc100.
2One patient finished an adjuvant CT (EC/Doc) before a palliative treatment (three cycles Carboplatin followed by two cycles Gemcitabine/Cisplatin) was started.